Condition: Gastric Cancer · Sponsor: Jagiellonian University
The study was designed to evaluate the efficacy of perioperative FLOT chemotherapy in combination with perioperative hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced gastric cancer at high risk of peritoneal metastases. The impact of treatment on peritoneal recurrence and survival over 6 months, 1, 3 and 5 years will be assessed.
This description comes directly from the study's public registry record.
Piotr Richter, Professor · +48124002400 · piotr.richter@uj.edu.pl
Always discuss trial participation with your own doctor first.
| Department of General, Oncological, Gastroenterological Surgery and Transplantology | Krakow, Lesser Poland Voivodship, Poland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04597294